BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11167877)

  • 1. Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer.
    Wigmore SJ; McMahon AJ; Sturgeon CM; Fearon KC
    Br J Surg; 2001 Feb; 88(2):255-60. PubMed ID: 11167877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
    McMillan DC; Canna K; McArdle CS
    Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
    Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
    Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.
    Canna K; Hilmy M; McMillan DC; Smith GW; McKee RF; McArdle CS; McNicol AM
    Colorectal Dis; 2008 Sep; 10(7):663-7. PubMed ID: 18005189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
    Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
    Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is C-reactive protein a prognostic factor of colorectal cancer?
    Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH
    Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of postoperative morbidity on long-term survival following liver resection for colorectal metastases.
    Laurent C; Sa Cunha A; Couderc P; Rullier E; Saric J
    Br J Surg; 2003 Sep; 90(9):1131-6. PubMed ID: 12945082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multivariate analysis of prognostic factors in colorectal cancer patients with different ages].
    Cai SR; Zheng S; Zhang SZ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):483-5. PubMed ID: 16188146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Young age is not a poor prognostic marker in colorectal cancer.
    Chung YF; Eu KW; Machin D; Ho JM; Nyam DC; Leong AF; Ho YH; Seow-Choen F
    Br J Surg; 1998 Sep; 85(9):1255-9. PubMed ID: 9752871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors after surgery in patients younger than 50 years old with colorectal adenocarcinoma.
    Mäkelä J; Kiviniemi H; Laitinen S
    Hepatogastroenterology; 2002; 49(46):971-5. PubMed ID: 12143256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ranitidine as adjuvant treatment in colorectal cancer.
    Nielsen HJ; Christensen IJ; Moesgaard F; Kehlet H;
    Br J Surg; 2002 Nov; 89(11):1416-22. PubMed ID: 12390384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency presentation of colorectal cancer is associated with poor 5-year survival.
    McArdle CS; Hole DJ
    Br J Surg; 2004 May; 91(5):605-9. PubMed ID: 15122613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of postoperative complications on long-term outcomes following curative resection for colorectal cancer.
    Law WL; Choi HK; Lee YM; Ho JW
    Ann Surg Oncol; 2007 Sep; 14(9):2559-66. PubMed ID: 17522945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
    Park JY; Lee KH
    Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative irradiation and surgery for local recurrence of rectal and rectosigmoid cancer. Prognostic factors with regard to survival and further local recurrence.
    Wiig JN; Larsen SG; Dueland S; Giercksky KE
    Colorectal Dis; 2008 Jan; 10(1):48-57. PubMed ID: 18028472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.